Skip to Main Content

WASHINGTON — It’s the literary equivalent of a campaign contribution: a well-placed op-ed piece, endorsing an agency nominee awaiting Senate confirmation. It’s How Washington Works. But few contenders have racked up the sheer number of public tributes as Scott Gottlieb, President Trump’s choice for FDA commissioner, who was confirmed by a Senate vote Tuesday.

Drug company lobbyists, academics with health industry funding, and a flurry of former colleagues have all picked up their pens on behalf of Gottlieb, the 44-year-old physician and former FDA deputy commissioner.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!